ACOX2 inhibitors are a class of compounds that affect the activity of acyl-CoA oxidase 2, an enzyme involved in the peroxisomal beta-oxidation of branched-chain fatty acids. This group of inhibitors includes various chemicals that do not act on ACOX2 directly but modulate the enzyme's activity through alterations in lipid metabolism, peroxisomal function, or gene expression related to fatty acid catabolism. The regulatory effects of these inhibitors are predominantly mediated by pathways that intersect with or influence the conditions required forACOX2 inhibitors are a class of compounds that affect the activity of acyl-CoA oxidase 2, an enzyme involved in the peroxisomal beta-oxidation of branched-chain fatty acids. This group of inhibitors includes various chemicals that do not act on ACOX2 directly but modulate the enzyme's activity through alterations in lipid metabolism, peroxisomal function, or gene expression related to fatty acid catabolism. The regulatory effects of these inhibitors are predominantly mediated by pathways that intersect with or influence the conditions required for optimal ACOX2 functionality.
The chemical complexity of ACOX2 inhibitors is widely varied, encompassing a range of distinct molecular structures and properties. They include synthetic compounds, drugs, and environmental contaminants, all of which can indirectly influence the enzymatic activity of ACOX2 through their interaction with metabolic pathways and regulatory systems. Their modes of action are diverse, operating through different mechanisms such as receptor-mediated transcriptional regulation, direct metabolic interference, or disruption of cellular structures and functions.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Triclosan | 3380-34-5 | sc-220326 sc-220326A | 10 g 100 g | $138.00 $400.00 | ||
Inhibits fatty acid synthesis by targeting the enoyl-ACP reductase component of the fatty acid synthase complex. Since ACOX2 is involved in the beta-oxidation of branched-chain fatty acids, an overload of fatty acids due to inhibition of their synthesis can reduce ACOX2 activity by substrate competition or feedback inhibition. | ||||||
Pentadecafluorooctanoic acid | 335-67-1 | sc-250662 sc-250662A | 5 g 25 g | $49.00 $149.00 | ||
PFOA has been shown to disrupt lipid metabolism and peroxisomal beta-oxidation, which could lead to altered ACOX2 activity. PFOA's interference in lipid homeostasis may result in negative modulation of ACOX2 function due to imbalances in the substrates or cofactors required for ACOX2 activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
As a dihydrofolate reductase inhibitor, methotrexate impacts one-carbon metabolism and indirectly affects lipid metabolism. This can influence the substrate availability for ACOX2, potentially leading to a reduction in its activity due to altered fatty acid profiles. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that interferes with hormonal regulation of metabolism. BPA can affect lipid metabolism and peroxisomal function, which may alter the activity of ACOX2 due to changes in the cellular environment and the available pool of substrates and cofactors. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
An anticonvulsant that has been observed to inhibit fatty acid beta-oxidation. Valproic acid's effect on mitochondrial and peroxisomal beta-oxidation pathways can indirectly lower ACOX2 activity by disrupting the normal catabolism of fatty acids. | ||||||
Bis(2-ethylhexyl) phthalate | 117-81-7 | sc-254975 | 1 g | $56.00 | 2 | |
Phthalates are known to be endocrine disruptors and can affect lipid metabolism. The interference with normal metabolic processes can lead to alterations in the activity of enzymes like ACOX2 due to changes in substrate availability or enzyme regulation. |